Getagraph.com logo
S&P 500
(1.03%) 5 180.74 points
Dow Jones
(0.46%) 38 852 points
Nasdaq
(1.19%) 16 349 points
Oil
(0.60%) $78.95
Gas
(-1.28%) $2.17
Gold
(0.23%) $2 336.60
Silver
(0.31%) $27.70
Platinum
(0.29%) $967.70
USD/EUR
(0.01%) $0.928
USD/NOK
(-0.03%) $10.82
USD/GBP
(-0.01%) $0.796
USD/RUB
(-0.01%) $91.33

Echtzeitaktualisierungen für Sosei Group Corporation [4565.T]

Börse: JPX Sektor: Healthcare Industrie: Biotechnology
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-05-08)

Expected move: +/- 0.00%

Zuletzt aktualisiert7 Mai 2024 @ 02:20
25% discount on Stockinvest.us - Use code: Podcast

0.00% ¥ 1 519.00

Live Chart Being Loaded With Signals

Commentary (7 Mai 2024 @ 02:20):

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis...

Stats
Tagesvolumen 130 400
Durchschnittsvolumen 1.36M
Marktkapitalisierung 135.87B
EPS ¥-2.13 ( 2024-02-13 )
Nächstes Ertragsdatum ( ¥35.75 ) 2024-05-08
Last Dividend ¥2.50 ( 2015-03-27 )
Next Dividend ¥0 ( N/A )
P/E -17.42
ATR14 ¥1.040 (0.07%)

Volumen Korrelation

Lang: -0.14 (neutral)
Kurz: -0.10 (neutral)
Signal:(53.491) Neutral

Sosei Group Corporation Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Sosei Group Corporation Korrelation - Währung/Rohstoff

The country flag -0.11
( neutral )
The country flag -0.06
( neutral )
The country flag -0.04
( neutral )
The country flag 0.36
( neutral )
The country flag 0.16
( neutral )
The country flag -0.34
( neutral )

Sosei Group Corporation Finanzdaten

Annual 2023
Umsatz: ¥12.77B
Bruttogewinn: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2023
Umsatz: ¥12.77B
Bruttogewinn: ¥7.87B (61.62 %)
EPS: ¥-87.17
FY 2022
Umsatz: ¥15.57B
Bruttogewinn: ¥14.64B (94.05 %)
EPS: ¥4.67
FY 2021
Umsatz: ¥17.71B
Bruttogewinn: ¥16.78B (94.73 %)
EPS: ¥12.53

Financial Reports:

No articles found.

Sosei Group Corporation Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A) 		¥0
(N/A)

Sosei Group Corporation Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend ¥2.50 2015-03-27
Last Dividend ¥2.50 2015-03-27
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out ¥2.50 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-05-07)
¥0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
8014.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7261.T Ex Dividend Knight 2023-09-28 Annually 0 0.00%
6493.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
5707.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
4527.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
3683.T Ex Dividend Junior 2023-12-28 Annually 0 0.00%
2982.T Ex Dividend Junior 2023-12-28 Annually 0 0.00%
1847.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
9842.T Ex Dividend Junior 2024-02-28 Semi-Annually 0 0.00%
8905.T Ex Dividend Knight 2024-02-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.5631.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.04581.200-1.525-1.830[0 - 0.3]
returnOnEquityTTM-0.1171.500-2.41-3.62[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.790.80010.008.00[1 - 3]
quickRatioTTM3.570.80010.008.00[0.8 - 2.5]
cashRatioTTM2.861.50010.0010.00[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM-3.341.000-2.35-2.35[3 - 30]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 20]
debtEquityRatioTTM1.048-1.5005.81-8.71[0 - 2.5]
grossProfitMarginTTM0.6971.0001.7231.723[0.2 - 0.8]
operatingProfitMarginTTM-0.6921.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.07531.000-1.530-1.530[0.2 - 2]
assetTurnoverTTM0.08120.800-2.79-2.23[0.5 - 2]
Total Score-1.525

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-18.891.000-2.010[1 - 100]
returnOnEquityTTM-0.1172.50-1.551-3.62[0.1 - 1.5]
freeCashFlowPerShareTTM-68.472.00-10.00-10.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-58.952.00-10.00-10.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.1601.500-4.400[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.4131.000-10.000[0.1 - 0.5]
Total Score-4.25

Sosei Group Corporation

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.